4
Changes in Ownership
Telix Pharmaceuticals Ltd Filed Acc 0001628280-26-061944
Group Chief Financial Officer bought 2,071 shares at $9.66 ($19,998)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Smith Darren Charlton Group Chief Financial Officer | 2026-09-07 | Purchase | +2,071 | $9.66 | $19,998 | 13,992 | D |
| Open-market purchases · 2,071 sh · avg $9.66 · $19,998 | |||||||
Loading xslF345X06/wk-form4_1789428011.xml…